NEW YORK--(BUSINESS WIRE)--Medidata (NASDAQ:MDSO), the leading global provider of cloud-based solutions for clinical research in life sciences, today announced the completion of MOVE-2014, a behavioral study the Company sponsored to test whether mobile health (mHealth) devices and tools could be used to drive better health outcomes in overweight adults with Type-2 Diabetes. The pilot open-label clinical trial is part of Medidata’s ongoing efforts to explore the challenges and opportunities asso
| < Prev | Next > |
|---|
